✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Ind-Swift Ltd.

INDSWFTLTD

Market Cap
₹93 Cr.
P/E
1.45

Ind-Swift Ltd.

  • Ind-Swift
  • Makers Laboratories
  • Biofil Chem & Pharma
  • TJI Pharma - Small Cap
FAQs on Ind-Swift Ltd. Shareprice

Ind-Swift has given better returns compared to its competitors.
Ind-Swift has grown at ~38.14% over the last 2yrs while peers have grown at a median rate of 10.31%

Ind-Swift is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Ind-Swift is 1.45, while 3 year average PE is 1.35.
Also latest EV/EBITDA of Ind-Swift is 26.56 while 3yr average is 26.59.

View FAQ's On Business
Growth Table
  • Ind-Swift Ltd.
  • Makers Laboratories
  • Biofil Chem & Pharma
Balance Sheet
  • Ind-Swift Ltd.
  • Makers Laboratories
  • Biofil Chem & Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Ind-Swift Ltd.
  • Makers Laboratories
  • Biofil Chem & Pharma
Cash Flow
  • Ind-Swift Ltd.
  • Makers Laboratories
  • Biofil Chem & Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Ind-Swift Ltd.
  • Makers Laboratories
  • Biofil Chem & Pharma
Quarterly Results
  • Ind-Swift Ltd.
  • Makers Laboratories
  • Biofil Chem & Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Ind-Swift Ltd. Financials

Ind-Swift balance sheet is weak and might have solvency issues

Yes, The net debt of Ind-Swift is increasing.
Latest net debt of Ind-Swift is ₹955 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹890 Crs.

The profit is oscillating.
The profit of Ind-Swift is ₹64.39 Crs for TTM, ₹14.23 Crs for Mar 2024 and ₹26.04 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ind-Swift latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech